- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Nobel Biocare Holding AG
+ Add to WatchlistNOBN:SW
12.150 CHF 0.050 0.41%As of 05:52:23 ET on 05/21/2013.
Snapshot for Nobel Biocare Holding AG (NOBN)
| Open: | 12.150 | Day's Range: | 11.950 - 12.200 | Volume: | 137,314 |
|---|---|---|---|---|---|
| Previous Close: | 12.100 | 52wk Range: | 6.944 - 12.250 | 1-Yr Rtn: | +21.29% |
Key Statistics for NOBN
| Current P/E Ratio (ttm) | 26.2318 |
|---|---|
| Estimated P/E(12/2013) | 24.5087 |
| Relative P/E vs. SMI | 1.2883 |
| Earnings Per Share (EUR) (ttm) | 0.3700 |
| Est. EPS (EUR) (12/2013) | 0.3960 |
| Est. PEG Ratio | 1.2947 |
| Market Cap (M CHF) | 1,497.79 |
| Shares Outstanding (M) | 123.78 |
| 30 Day Average Volume | 598,126 |
| Price/Book (mrq) | 3.7678 |
| Price/Sale (ttm) | 2.0878 |
| Dividend Indicated Gross Yield | 1.65% |
| Cash Dividend (CHF) | 0.2000 |
| Last Dividend | 04/03/2013 |
| 5 Year Dividend Growth | -26.77% |
| Next Earnings Announcement | 08/22/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for NOBN
Company Profile & Key Executives for NOBN
Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.
| Richard T LaubeChief Executive Officer | Oliver WalkerChief Financial Officer |
| Hans GeiselhoringerExec VP:Global Research | Melker NilssonExec VP:Global Customer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
NOBN News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page